AIBN researchers want HIV patients to have the option of taking a long-acting antiretroviral dose once a week, instead of having to take a dose every day.
From sunscreens to vaccines, most of the modern technology we rely on today is dependent on our ability to precisely manufacture complex molecules with precise chemical properties.
Associate Professor Joy Wolfram leads a nanomedicine and extracellular vesicle research program with the goal of developing innovative approaches that bring the next generation of treatments and diagnostics directly to the clinic.
Liposomes are self-assembling lipid-based nanoparticles that enclose an aqueous core. An advantage of liposomes is versatility in terms of efficient loading of both hydrophilic and hydrophobic therapeutics.
